tirzepatide trial obesity without diabetes enhances weight loss with sustained treatment but discontinuation leads to weight regain Tirzepatide Beyond Diabetes and Obesity:

Red flag symptoms requiring urgent assessment include: Severe abdominal pain or distension that is progressive or unrelieved Nausea and vomiting, particularly if unable to tolerate oral intake Inability to pass gas or persistent vomiting (possible signs of obstruction) Rectal bleeding or black, tarry stools suggesting gastrointestinal bleeding Unintentional weight loss beyond expected therapeutic effects Fever accompanying constipation, which may indicate infection or inflammation Signs of dehydration (extreme thirst, dry mouth, dizziness, dark urine) Patients with pre-existing gastrointestinal conditionsincluding inflammatory bowel disease, previous bowel obstruction, or diverticular diseaseshould have lower thresholds for seeking medical advice

The initial question posed by this post is one we're asked very frequently

It can activate hormone pathways that support insulin release when blood sugar is high

As their use grows their side effects make headlines